Background : The use of drugs such as bisphosphonates has been linked to adverse effects, such as osteonecrosis of the jaws associated with medication. Resveratrol has characteristics anti-oxidant, anti-inflammatory, antiresorptive and effects on apoptosis control and this substance could be important in preventing the occurrence of MRONJ associated with bisphosphonates.Aim/Hypothesis : This study aimed at verifying the effect of resveratrol (RESV) on the prevention of medication-related osteonecrosis of the jaws (MRONJ) in estrogen-deficient rats treated with zoledronate (ZLD). Material and Methods: Fifth adult Wistar rats distributed in the following groups-(1) OVT; RESV ( n -10)-ovariectomy; resveratrol; (2) OVT; PLA ( n -10)-ovariectomy; placebo; (3) OVT; ZLD ( n -10)-ovariectomy; zoledronate, (4) OVT; RESV; ZLD ( n -10)-ovariectomy; resveratrol; zoledronate, (5) SHAM;PLAC ( n -10)-no ovariectomy; placebo. The ONM was induced by means of the exodontia of the lower molars bilater-ally. After euthanasia, the left hemi-jaws were submitted to computerized microtomography (Micro-CT) and after that to immunohistochemistry. The right hemi-jaws were collected for analysis of gene expression. The animals' blood was also collected for the serum analysis of the Carboxyterminal Telopeptide of Type I Collagen (CTX), through Elisa. Data were submitted to statistical analysis using the ANOVA Tukey or Kruskal Wallis Dunn tests, with a significance level of 5%.Results : Histomorphometric analysis showed that zoledronate increased the percentage of non-vital bone tissue (TONV) and reduced the percentage of (neo-formed bone tissue) TONF compared to the groups that did not receive zoledronate ( P < 0.05). In addition, when resveratrol was administrated isolated, higher TONF values were observed comparing to OVT;ZOL; PLAC group ( P < 0.05). The number of TRAP-positive cells reduced in the presence of zoledronate ( P < 0.05), while the mRNA levels of TRAP increased with ZLD treatment, with or without resveratrol in relation to the other groups ( P < 0.05). Treatment with resveratrol increased SOD levels when compared to OVT; ZLD; PLAC and OVT; ZLD; RESV ( P < 0.05). Conclusion and ClinicalImplications : It can be concluded that resveratrol reduced MRONJ induced by zoledronic acid in estrogen-deficient rats. And as a clinical implications the chronic and systemic use of resveratrol may prevent the appearance of osteonecrosis of the jaws associated with medications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.